Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Mollee

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|September 5, 2025
Real-World Comparison of Treatment Outcomes for Multiple Myeloma in Elderly Transplant Ineligible Patients Receiving First-Line VRd, Rd and VCd: Results From the Australian and New Zealand Myeloma and Related Diseases RegistrySarah Zhao, Cameron Wellard, Elizabeth M Moore, et al.
Medicine and Science in Sports and Exercise|August 3, 2023
Safety, Feasibility, and Acceptability of a Multisite Individualized Exercise Intervention for People with Multiple MyelomaJennifer L Nicol, Brent J Cunningham, Carmel Woodrow, et al.
BMC Medical Research Methodology|November 11, 2016
Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registryKrystal Bergin, Elizabeth Moore, Zoe McQuilten, et al.
American Journal of Blood Research|March 21, 2012
Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8 T-cell epitopesDo Nguyen-Van, Colm Keane, Erica Han, et al.
Internal Medicine Journal|February 8, 2018
Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myelomaHang Quach, Simon Benson, Helen Haysom, et al.
Plos One|August 27, 2024
Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registryAdam Irving, Dennis Petrie, Anthony Harris, et al.
Pathology|January 7, 2020
A practical guide to laboratory investigations at diagnosis and follow up in Waldenström macroglobulinaemia: recommendations from the Medical and Scientific Advisory Group, Myeloma Australia, the Pathology Sub-committee of the Lymphoma and Related Diseases Registry and the Australasian Association of Clinical Biochemists Monoclonal Gammopathy Working GroupM Gohar Maqbool, Constantine S Tam, Ian M Morison, et al.
Internal Medicine Journal|December 8, 2022
Current approaches to the diagnosis and management of amyloidosisMark S Taylor, Hasib Sidiqi, James Hare, et al.
Frontiers in Cardiovascular Medicine|July 19, 2023
Cardiac "hypertrophy" phenotyping: differentiating aetiologies with increased left ventricular wall thickness on echocardiographyAaisha Ferkh, Catherina Tjahjadi, Luke Stefani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphomaMaher K Gandhi, Eleanore Lambley, Jacqueline Burrows, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Clinical Lymphoma, Myeloma & Leukemia|September 5, 2025
Real-World Comparison of Treatment Outcomes for Multiple Myeloma in Elderly Transplant Ineligible Patients Receiving First-Line VRd, Rd and VCd: Results From the Australian and New Zealand Myeloma and Related Diseases RegistrySarah Zhao, Cameron Wellard, Elizabeth M Moore, et al.
Medicine and Science in Sports and Exercise|August 3, 2023
Safety, Feasibility, and Acceptability of a Multisite Individualized Exercise Intervention for People with Multiple MyelomaJennifer L Nicol, Brent J Cunningham, Carmel Woodrow, et al.
BMC Medical Research Methodology|November 11, 2016
Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registryKrystal Bergin, Elizabeth Moore, Zoe McQuilten, et al.
American Journal of Blood Research|March 21, 2012
Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8 T-cell epitopesDo Nguyen-Van, Colm Keane, Erica Han, et al.
Internal Medicine Journal|February 8, 2018
Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myelomaHang Quach, Simon Benson, Helen Haysom, et al.
Plos One|August 27, 2024
Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registryAdam Irving, Dennis Petrie, Anthony Harris, et al.
Pathology|January 7, 2020
A practical guide to laboratory investigations at diagnosis and follow up in Waldenström macroglobulinaemia: recommendations from the Medical and Scientific Advisory Group, Myeloma Australia, the Pathology Sub-committee of the Lymphoma and Related Diseases Registry and the Australasian Association of Clinical Biochemists Monoclonal Gammopathy Working GroupM Gohar Maqbool, Constantine S Tam, Ian M Morison, et al.
Internal Medicine Journal|December 8, 2022
Current approaches to the diagnosis and management of amyloidosisMark S Taylor, Hasib Sidiqi, James Hare, et al.
Frontiers in Cardiovascular Medicine|July 19, 2023
Cardiac "hypertrophy" phenotyping: differentiating aetiologies with increased left ventricular wall thickness on echocardiographyAaisha Ferkh, Catherina Tjahjadi, Luke Stefani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphomaMaher K Gandhi, Eleanore Lambley, Jacqueline Burrows, et al.
Pageof 15